As part of its ongoing expansion plans, ProAxsis Limited, the Belfast-based diagnostics company, is pleased to announce two new appointments within …
Type and hit ENTER
David Ribeiro
ProAxsis Limited (www.proaxsis.com), the Belfast-based respiratory diagnostics company, is delighted to announce it has entered into an exclusive licensing agreement with …
June 7, 2021
Posted by David Ribeiro
ProAxsis (www.proaxsis.com), the Belfast-based diagnostics company, and a collaboration of the University of Geneva and the University Hospital of Geneva, today …
February 21, 2021
Posted by David Ribeiro
ProAxsis Limited (www.proaxsis.com), the Belfast-based diagnostics company specialising in the measurement of active proteases and other inflammatory biomarkers, today announces that …
December 14, 2020
Posted by David Ribeiro
ProAxsis (www.proaxsis.com), the Belfast-based respiratory diagnostics company, today announces that it has been awarded a high impact Innovate UK grant as …
December 10, 2020
Posted by David Ribeiro
ProAxsis (www.proaxsis.com), the Belfast-based protease diagnostics company, is delighted to announce that it has been recognised as a Gold Level Innovator …
December 2, 2020
Posted by David Ribeiro
ProAxsis Limited (www.proaxsis.com), the Belfast-based diagnostics company specialising in the measurement of active proteases and other inflammatory biomarkers, today announces that …
November 19, 2020
Posted by David Ribeiro
ProAxsis Limited (www.proaxsis.com), the Belfast-based diagnostics company specialising in the measurement of active proteases and other inflammatory biomarkers, today announces a significant …
October 16, 2020
Posted by David Ribeiro
ProAxsis (www.proaxsis.com), the Belfast-based respiratory diagnostics company, today announces that it has been awarded an Innovate UK grant as part of …
August 3, 2020
Posted by David Ribeiro
Belfast based respiratory diagnostics company, ProAxsis is investing over £200,000 in R&D to enhance its novel ProteaseTag® technology. The company is …
July 27, 2020
Posted by David Ribeiro
ProAxsis (www.proaxsis.com), the Belfast-based diagnostics company, today announces that it will be conducting a collaborative 12-month project with the Northern Ireland …
July 9, 2020
Posted by David Ribeiro
ProAxsis (www.proaxsis.com), the Belfast-based diagnostics company, has formed a new partnership with Ulster University, the largest university in Northern Ireland. The …
June 29, 2020
Posted by David Ribeiro
ProAxsis Limited, the Belfast-based diagnostics company, is pleased to welcome back Elisha Cain, who re-joins the company in the newly created …
June 23, 2020
Posted by David Ribeiro
ProAxsis is delighted to have been shortlisted for a Business Eye First Trust Award for the second year running. Having been …
November 18, 2019
Posted by David Ribeiro
ProAxsis was delighted to support the recent School of Pharmacy Undergraduate Awards at Queen’s University, Belfast. For the second year running, the …
October 25, 2019
Posted by David Ribeiro
ProAxsis is pleased to confirm that Professor Stephen Smith has become the Chairman of the company’s Board of Directors with immediate …
October 25, 2019
Posted by David Ribeiro
The potential benefits of ProAxsis’ novel ProteaseTag® Active Proteinase 3 Immunoassay will be discussed at the Winter meeting of the British Thoracic …
November 26, 2018
Posted by David Ribeiro
ProAxsis Limited (www.proaxsis.com), the Belfast-based company focused on developing new assays for the measurement of active protease biomarkers of disease, today announces …
September 20, 2018
Posted by David Ribeiro
ProAxsis will today be presenting new data on its highly novel active neutrophil elastase (NE) point-of-care test, NEATstik®, at the European …
September 18, 2018
Posted by David Ribeiro
ProAxsis Limited (www.proaxsis.com), the Belfast-based company focused on developing new assays for the measurement of active protease biomarkers of disease, today announces …
August 2, 2018
Posted by David Ribeiro
ProAxsis will be presenting three abstracts at the COPD 11 Conference, which takes place between June 20th-21st 2018 in Birmingham, UK. …
June 18, 2018
Posted by David Ribeiro
ProAxsis Limited has been declared as the “Innovative Business of the Year” at the Business Eye First Trust Awards (BEFTAs) for …
June 4, 2018
Posted by David Ribeiro
ProAxsis Limited has received an Invest NI Grant for Research and Development, supporting the company to develop new products using its innovative …
June 1, 2018
Posted by David Ribeiro
ProAxsis confirms that new data on its ProteaseTag® technology will be presented at the American Thoracic Society Conference, which takes place …
May 2, 2018
Posted by David Ribeiro
ProAxsis is proud to be collaborating with Dr. Gunnar Schroeder and Prof. Cliff Taggart from the School of Medicine, Dentistry and …
March 6, 2018
Posted by David Ribeiro
Following on from the commercialisation update provided in November, ProAxsis is pleased to report the first sale of NEATstik®, the company’s novel …
February 15, 2018
Posted by David Ribeiro
ProAxsis Ltd
Unit 1B, Concourse Building 3,
Catalyst Inc,
Queen’s Road, Titanic Quarter,
Belfast,
BT3 9DT,
Northern Ireland
tel +44 (0)28 9073 0444
email info@proaxsis.com
RECENT NEWS
-
June 7, 2021
ProAxsis signs global in-licensing agreement with AstraZeneca for COVID-19 serology test
-
May 21, 2021
ProAxsis Ltd CEO Update Report – May 2021
-
February 21, 2021
ProAxsis Limited enters licensing agreement with top Swiss University as it continues to develop novel new products in the fight against fractures and other metabolic bone diseases
Copyright © 2016-2021 - ProAxsis - All rights reserved.
David Ribeiro, Author at ProAxsis